MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
MCKESSON CORP
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1010.43+5.59 (+0.56%)
Close on Oct 19, 2026
- Market cap
- $120.44B
- P/E (TTM)
- 27.1
- Dividend yield
- 0.31%
MCKESSON CORP revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North American Pharmaceutical | $336.65B | $304.51B | $261.37B | – | – | – | – | – | – | – | 83.4% | +10.6% |
| Oncology & Multispecialty | $48.42B | $36.86B | $30.49B | – | – | – | – | – | – | – | 12.0% | +31.4% |
| Medical-Surgical Solutions | $11.51B | $11.38B | $11.31B | $11.11B | $11.61B | $10.10B | $8.31B | $7.62B | – | – | 2.9% | +1.1% |
| Prescription Technology Solutions | $5.81B | $5.22B | $4.77B | $4.39B | $3.86B | $2.89B | $2.71B | $2.49B | – | – | 1.4% | +11.3% |
| Technology Solutions | – | – | – | – | – | – | – | – | $240.00M | $2.61B | – | – |
| Distribution Solutions | – | – | – | – | – | – | – | – | $208.12B | $195.92B | – | – |
| European Pharmaceutical Solutions | – | – | – | – | – | – | $27.39B | $27.24B | $27.32B | $24.85B | – | – |
| Medical-Surgical Solutions | – | – | – | – | – | – | $8.31B | $7.62B | $6.61B | $6.24B | – | – |
| U.S. Pharmaceutical and Specialty Solutions | – | – | – | – | – | – | $183.34B | $167.76B | $162.59B | $155.24B | – | – |
| Other Segments [Member] | – | – | – | – | – | – | $12.02B | $11.70B | $11.84B | $12.21B | – | – |
| International | – | $14.72B | $14.13B | $20.60B | $36.35B | $35.97B | $38.34B | $38.02B | – | – | – | – |
| U.S. Pharmaceutical | – | $327.72B | $278.74B | $240.62B | $212.15B | $189.27B | $181.70B | $166.19B | – | – | – | – |
| Operating income | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Technology Solutions | – | – | – | – | – | – | – | – | -$23.00M | $4.22B | – |
| Distribution Solutions | – | – | – | – | – | – | – | – | $1.23B | $3.36B | – |
By product or service
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | – | – | $192.71B | $176.30B | $169.94B | $164.43B | – | – |
| Foreign | – | – | – | – | – | – | $38.34B | $38.02B | $38.41B | $34.11B | – | – |
From the segment and revenue-disaggregation notes of Mckesson's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.